Skip to main content
SpringerLink
Log in

ICIs: safety profiles and risks of immune-related serious AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Oliveira C, et al. Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis European Journal of Clinical Pharmacology : 19 Feb 2024. Available from: URL: https://doi.org/10.1007/s00228-024-03647-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICIs: safety profiles and risks of immune-related serious AEs. Reactions Weekly 1998, 11 (2024). https://doi.org/10.1007/s40278-024-53855-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53855-9

Search

Navigation